Avicanna Announces Results of Annual General and Special Meeting
TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the c…